Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BZFD vs AKAN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

AKAN Captures Overall Composite Edge (39.8 SELL vs 51.3 HOLD), While BZFD Leads 4–2 on Growth & Valuation Pillars

AKAN Overall Winner 6-Pillar Tally: BZFD 4 – 2 AKAN Matrix Metrics: BZFD 4 – 4 AKAN

As of Nov 20, 2026, Akanda Corp. Common Shares (AKAN) captures the overall head-to-head institutional edge over BuzzFeed, Inc. (BZFD) on higher Unified Composite conviction (39.8/100 SELL vs. 51.3/100 HOLD) after splitting the core matrix 4–4 (led by Growth & Scale, Balance Sheet & Cash Flow), while BZFD wins 4–2 across the 6-pillar growth and valuation breakdown. BZFD trades at $0.38 (N/M Forward P/E, -17.7% operating margin) versus AKAN at $4.23 (N/M Forward P/E, -1254.5% operating margin).

  • Composite vs. Pillar Nuance: While BZFD currently prints a higher short-term Unified Composite Score (51.3/100 HOLD vs. AKAN 39.8/100 SELL), AKAN captures the overall institutional head-to-head verdict (4–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (-1254.5% vs. -17.7% operating margin) and revenue trajectory (+21.9% vs. -43.8% YoY).
  • Technical & Structure Timing Caution: BZFD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3); meanwhile AKAN is in a Breakdown options structure phase (RSI 75.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BZFD vs AKAN
BZFD NASDAQ
BuzzFeed, Inc. Class A Common Stock
Communications Services, Nec
$0.38
+2.79% 1D
Market Cap $38.1M
TTM Revenue $150M
Forward P/E N/M
Beta / 30D Vol 2.52β · 192% Vol
Unified Composite Score
51.3 / 100 HOLD
Tech 55.0 Fund 52.0 Flow 60.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -16.7%), weak momentum, RSI 25
RSI-14: 25.3 · SMA20: $0.65 · SMA50: $0.91
AKAN NASDAQ Head-to-Head Winner
Akanda Corp. Common Shares
Medicinal Chemicals & Botanical Products
$4.23
+23.32% 1D
Market Cap $12.2M
TTM Revenue $662,469
Forward P/E N/M
Beta / 30D Vol 4.82β · 524% Vol
Unified Composite Score
39.8 / 100 SELL
Tech 15.0 Fund 36.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 75
RSI-14: 75.2 · SMA20: $1.52 · SMA50: $1.88

6-Pillar Scorecard Institutional Category Breakdown (BZFD 4 – 2 AKAN)

Columns: Metric · BZFD · AKAN
1. Valuation Multiples BZFD
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.5x 18.5x
2. Growth & Scale AKAN
Revenue Growth (YoY) -43.8% +21.9%
Earnings Growth (YoY) -54.7% +0.0%
TTM Revenue (USD) $150M $662,469
Market Cap $38.1M $12.2M
3. Profitability & Quality BZFD
Gross Margin 40.5% -12.0%
Operating Margin -17.7% -1254.5%
Net Profit Margin -48.0% 0.0%
Return on Equity (ROE) -123.0% -60.9%
4. Balance Sheet & Cash Flow AKAN
Cash Generation (TTM) -$39M -$7.9M EBITDA
Cash Flow Margin -26.2% N/A
Net Cash / Leverage $39M Net Debt (1.18x D/E) -60.9% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning BZFD
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 319.8% (50th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat BZFD
OpEx & R&D Intensity 58.2% of Rev ($88M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Internet Content & Information Operator Drug Manufacturers - Specialty & Generic Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BZFD (4) vs AKAN (4)
Institutional Metric BZFD AKAN Criterion Row Edge
Market Capitalization
Scale
$38.1M $12.2M Larger Scale BZFD
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
-43.8% +21.9% Higher Growth AKAN
Operating Margin (TTM)
Profitability
-17.7% -1254.5% Higher Margin BZFD
Net Profit Margin
Profitability
-48.0% 0.0% Higher Margin AKAN
Return on Equity (ROE)
Capital Efficiency
-123.0% -60.9% Higher ROE AKAN
52-Week Range Position
Momentum
2% ($0–$2) 5% ($0–$79) Stronger Trend AKAN
Beta / 30D Volatility
Risk Regime
2.52β · 192% Vol 4.82β · 524% Vol Lower Realized Risk BZFD
Unified Institutional Score
Composite Signal
51.3 / 100 (HOLD) 39.8 / 100 (SELL) Higher Composite BZFD
Trailing 12M Revenue (USD)
Operating Scale
$150M $662,469 FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
40.5% -12.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.5x EV/Rev N/M PEG · 18.5x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$39M ($39M Net Debt (1.18x D/E)) -$7.9M EBITDA (-60.9% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon AKAN +329.14 pp
BZFD: -61.31% · AKAN: +267.83%
3M Horizon AKAN +80.96 pp
BZFD: -66.79% · AKAN: +14.17%
6M Horizon BZFD +2.36 pp
BZFD: -82.04% · AKAN: -84.4%
1Y Horizon AKAN +418.3 pp
BZFD: -60.01% · AKAN: +358.29%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BZFD vs AKAN. Trailing 12-month operating profitability (BZFD -17.7% vs AKAN -1254.5%) and valuation multiples (BZFD N/M vs AKAN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

BZFD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$150M
Gross Margin40.5%
Op. Margin-17.7%
ROE / Fwd P/E-123.0% · N/M
AKAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$662,469
Gross Margin-12.0%
Op. Margin-1254.5%
ROE / Fwd P/E-60.9% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BZFD BREAKDOWN
126d in phase · OBV NEUTRAL
Current IV 319.8%
IV Percentile 50th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact BZFD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
AKAN BREAKDOWN
140d in phase · OBV ACCUMULATION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact AKAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BZFD Moat Profile Cyclical / Execution-Driven Positioning
Internet Content & Information Operator
Competes within the Internet Content & Information value chain with $38.1M market capitalization and -17.7% operating margin.
OpEx & R&D Reinvestment 58.2% of Rev ($88M)
90D Engineering Disclosures 0 Published
AKAN Moat Profile Cyclical / Execution-Driven Positioning
Drug Manufacturers - Specialty & Generic Operator
Competes within the Drug Manufacturers - Specialty & Generic value chain with $12.2M market capitalization and -1254.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ BZFD vs AKAN Key Questions & Quantitative Answers

As of Nov 20, 2026, Akanda Corp. Common Shares (AKAN) captures the overall head-to-head institutional edge over BuzzFeed, Inc. (BZFD) on higher Unified Composite conviction (39.8/100 SELL vs. 51.3/100 HOLD) after splitting the core matrix 4–4 (led by Growth & Scale, Balance Sheet & Cash Flow), while BZFD wins 4–2 across the 6-pillar growth and valuation breakdown. BZFD trades at $0.38 (N/M Forward P/E, -17.7% operating margin) versus AKAN at $4.23 (N/M Forward P/E, -1254.5% operating margin). Composite vs. Pillar Nuance: While BZFD currently prints a higher short-term Unified Composite Score (51.3/100 HOLD vs. AKAN 39.8/100 SELL), AKAN captures the overall institutional head-to-head verdict (4–4 matrix metrics and 2–4 across the 6 pillars) due to superior fundamental profitability (-1254.5% vs. -17.7% operating margin) and revenue trajectory (+21.9% vs. -43.8% YoY). Technical & Structure Timing Caution: BZFD is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 25.3); meanwhile AKAN is in a Breakdown options structure phase (RSI 75.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

AKAN leads the Growth & Scale pillar: BZFD posts -43.8% YoY revenue growth and -54.7% YoY earnings growth on $150M TTM revenue (40.5% gross margin, -17.7% operating margin), compared with AKAN at +21.9% YoY revenue growth and +0.0% YoY earnings growth on $662,469 TTM revenue (-12.0% gross margin, -1254.5% operating margin). On trailing 12-month operating scale, BZFD generates $150M in USD-normalized revenue versus $662,469 for AKAN. In operating R&D and SG&A reinvestment, BZFD deploys 58.2% of Rev ($88M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for AKAN.

BZFD screens cheaper on headline valuation multiples. BZFD trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.5x EV/Revenue (-26.2% FCF margin), whereas AKAN trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 18.5x EV/Revenue (unreported EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BZFD (-123.0% ROE) versus AKAN (-60.9% ROE) capital efficiency.

In options market volatility and institutional positioning, BZFD carries 319.8% implied volatility (50th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (2.52β · 192% Vol realized risk). By comparison, AKAN carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a BREAKDOWN options structure phase (4.82β · 524% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.